← Back to patent-cliff list
CAS 1452584-66-5
(4-(6,7-dioxohept-1-yn-4-yl)benzoyl)-L-glutamic acid
Codes：PRAL-029
Application context (from source-drug indications)
外周T细胞淋巴瘤普拉曲沙T-细胞淋巴瘤普拉曲沙实体瘤普拉曲沙血液肿瘤普拉曲沙B-细胞淋巴瘤普拉曲沙皮肤T细胞淋巴瘤普拉曲沙
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 普拉曲沙Pralatrexate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
dimethyl (4-(6,7-dioxohept-1-yn-4-yl)benzoyl)-L-glutamate→(4-(6,7-dioxohept-1-yn-4-yl)benzoyl)-L-glutamic acid→pyrimidine-2,4,5,6-tetraamine dihydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.